# Lazard, Inc.: overview

LAZ · NYSE · CIK 1311370 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/laz.md) · [Financials](/companies/laz/financials.md) · [Filings](/companies/laz/filings.md) · [Insiders](/companies/laz/insiders.md)

Latest reported revenue: [$836.4m](/filings/0001311370-26-000027.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 26, 2026 (XBRL us-gaap:Revenues, accession 0001311370-26-000027).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [839 d](/filings/0001311370-26-000008.md) | [669](/filings/0001311370-26-000015.md) | [817](/filings/0001311370-26-000022.md) | [771](/filings/0001311370-26-000027.md) | [929 d](/filings/0001311370-26-000008.md) | [779](/filings/0001311370-26-000015.md) | [830](/filings/0001311370-26-000022.md) | [836](/filings/0001311370-26-000027.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [12.8% d](/filings/0001311370-26-000008.md) | [8.2%](/filings/0001311370-26-000015.md) | [11.4%](/filings/0001311370-26-000022.md) | [12.3%](/filings/0001311370-26-000027.md) | [9.1% d](/filings/0001311370-26-000008.md) | [11.5%](/filings/0001311370-26-000015.md) | [4.5%](/filings/0001311370-26-000022.md) | [6.5%](/filings/0001311370-26-000027.md) |
| Net margin | % | [10.3% d](/filings/0001311370-26-000008.md) | [9.0%](/filings/0001311370-26-000015.md) | [6.8%](/filings/0001311370-26-000022.md) | [9.2%](/filings/0001311370-26-000027.md) | [5.4% d](/filings/0001311370-26-000008.md) | [12.9%](/filings/0001311370-26-000015.md) | [0.6%](/filings/0001311370-26-000022.md) | [3.5%](/filings/0001311370-26-000027.md) |
| Diluted EPS | $ per share | not reported | [0.56](/filings/0001311370-26-000015.md) | [0.52](/filings/0001311370-26-000022.md) | [0.65](/filings/0001311370-26-000027.md) | not reported | [0.91](/filings/0001311370-26-000015.md) | [0.03](/filings/0001311370-26-000022.md) | [0.26](/filings/0001311370-26-000027.md) |
| Free cash flow | $m | [348 d](/filings/0001311370-26-000008.md) | [(231)](/filings/0001311370-26-000015.md) | [38.0 d](/filings/0001311370-26-000022.md) | [285 d](/filings/0001311370-26-000027.md) | [396 d](/filings/0001311370-26-000008.md) | [(221)](/filings/0001311370-26-000015.md) | [199 d](/filings/0001311370-26-000022.md) | [311 d](/filings/0001311370-26-000027.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,274](/filings/0001628280-24-006659.md) | [2,855](/filings/0001628280-25-007441.md) | [2,593](/filings/0001311370-26-000008.md) | [3,140](/filings/0001311370-26-000008.md) | [3,186](/filings/0001311370-26-000008.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [22.1%](/filings/0001628280-24-006659.md) | [18.1%](/filings/0001628280-25-007441.md) | [(3.1%)](/filings/0001311370-26-000008.md) | [12.3%](/filings/0001311370-26-000008.md) | [10.3%](/filings/0001311370-26-000008.md) |
| Net margin | % | [16.1%](/filings/0001628280-24-006659.md) | [12.5%](/filings/0001628280-25-007441.md) | [(2.9%)](/filings/0001311370-26-000008.md) | [8.9%](/filings/0001311370-26-000008.md) | [7.4%](/filings/0001311370-26-000008.md) |
| Diluted EPS | $ per share | [4.63](/filings/0001628280-24-006659.md) | [3.51](/filings/0001628280-25-007441.md) | [(0.90)](/filings/0001311370-26-000008.md) | [2.68](/filings/0001311370-26-000008.md) | [2.17](/filings/0001311370-26-000008.md) |
| Free cash flow | $m | [826](/filings/0001628280-24-006659.md) | [784](/filings/0001628280-25-007441.md) | [136](/filings/0001311370-26-000008.md) | [697](/filings/0001311370-26-000008.md) | [487](/filings/0001311370-26-000008.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/laz/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $467.7m | 11,152,391 |  | Added +540,481 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $379.1m | 9,038,924 |  | Added +1,458,896 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $257.3m | 6,136,015 |  | Added +1,182,289 |
| [ARIEL INVESTMENTS, LLC](/funds/936753.md) | 2026-06-30 | $241.4m | 5,755,404 |  | Reduced −70,885 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $210.6m | 5,021,304 |  | Added +58,215 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $152.4m | 3,632,893 |  | Added +1,750,301 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $125.3m | 2,986,539 |  | Added +2,046,647 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $107.5m | 2,561,497 |  | Added +96,584 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $94.0m | 2,242,241 |  | Reduced −214,485 |
| [Fisher Asset Management, LLC](/funds/850529.md) | 2026-06-30 | $90.1m | 2,148,377 |  | Reduced −22,468 |

## Recent filings

[All 1,518 filings](/companies/laz/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:31 ET | [10-Q](/filings/0001311370-26-000027.md) | Quarterly report, period 2026-09-30 | 0001311370-26-000027 |
| 2026-10-22 | 06:31 ET | [8-K](/filings/0001628280-26-066781.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-066781 |
| 2026-10-13 | 17:06 ET | [8-K](/filings/0001628280-26-065756.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-065756 |
| 2026-07-28 | 16:33 ET | [10-Q](/filings/0001311370-26-000022.md) | Quarterly report, period 2026-06-30 | 0001311370-26-000022 |
| 2026-07-23 | 06:30 ET | [8-K](/filings/0001628280-26-049278.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-049278 |
| 2026-07-07 | 08:31 ET | [8-K](/filings/0001628280-26-047432.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-047432 |
| 2026-05-22 | 17:19 ET | [8-K](/filings/0001628280-26-037801.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-037801 |
| 2026-05-04 | 16:41 ET | [10-Q](/filings/0001311370-26-000015.md) | Quarterly report, period 2026-03-31 | 0001311370-26-000015 |
| 2026-05-01 | 16:27 ET | [8-K](/filings/0001628280-26-029365.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-029365 |
| 2026-05-01 | 06:31 ET | [8-K](/filings/0001628280-26-029091.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-029091 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001311370-26-000008.md), filed Feb 23, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1311370
- Tickers: LAZ
- Exchange: NYSE
- SIC code: 6282 Investment Advice
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:54 ET. No prices; not investment advice.